The DEA's top administrative law judge will hear expert testimony and digest evidence on marijuana's status under federal law ...

The DEA judge says a "narrow" set of issues will determine if it's reclassified as Schedule III. Reformers have concerns ...

Attorney Matt Zorn is suing the Drug Enforcement Administration (DEA) for failing to release records related to its ...

DEA holds hearing on rescheduling marijuana from Schedule I to Schedule III. Public comments and expert testimonies weigh in.

The DEA will hold hearings on whether to lessen restrictions on marijuana where it would be in the same class of drugs as ...

DEA to hold hearing on rescheduling marijuana to Schedule III on December 2, focusing on logistics, not testimonies. Debate ...

The Drug Enforcement Administration (DEA) issued an advisory on Tuesday to notify the public about an initial hearing on the ...

The Drug Enforcement Administration (DEA) is moving forward with its proposal to reschedule marijuana from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA).

President-elect Donald Trump’s choice to lead the DEA is a Florida sheriff who favored decriminalizing small amounts of ...

And there's no reason to keep cannabis in the Controlled Substances Act,” Wexler told USA TODAY ahead of the DEA announcement. What are the possible risks of marijuana? Because of its ...

A researcher has filed a lawsuit against the Drug Enforcement Administration, accusing the agency of multiple legal violations in its process of marijuana rescheduling.

DEA's marijuana rescheduling hearings could reshape cannabis policy, easing research and tax rules while stopping short of full legalization.